Literature DB >> 16162476

Stress up-regulates neuronal expression of the herpes simplex virus type 2 large subunit of ribonucleotide reductase (R1; ICP10) by activating activator protein 1.

Michael D Gober1, Samantha Q Wales, J Colin Hunter, Bhuvnesh K Sharma, Laure Aurelian.   

Abstract

Herpes simplex virus type 2 (HSV-2) genes expressed in neuronal cells in response to stress stimuli that trigger latency reactivation are largely unknown. Using a chloramphenicol acetyltransferase (CAT) reporter assay we found that stress caused a significant (P < .001) increase in ICP10 expression in neuronal cells. Up-regulation correlated with activator protein (AP)-1 activation, notably c-Jun and c-Fos that bind cognate elements in the ICP10 promoter. It was blocked by mutation of the AP-1 motifs in the ICP10 promoter. ICP10 expression protected neuronal cells from stress-induced apoptosis. The data suggest that ICP10 may contribute to HSV-2 reactivation by increasing neuronal survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162476     DOI: 10.1080/13550280591002423

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  40 in total

1.  A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells.

Authors:  C C Smith; Y X Yu; M Kulka; L Aurelian
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  The R1 subunit of herpes simplex virus ribonucleotide reductase has chaperone-like activity similar to Hsp27.

Authors:  Stéphane Chabaud; Herman Lambert; A Marie-Josée Sasseville; Hugo Lavoie; Claire Guilbault; Bernard Massie; Jacques Landry; Yves Langelier
Journal:  FEBS Lett       Date:  2003-06-19       Impact factor: 4.124

3.  A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs.

Authors:  M Wachsman; M Kulka; C C Smith; L Aurelian
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

4.  Inducible cyclic AMP early repressor produces reactivation of latent herpes simplex virus type 1 in neurons in vitro.

Authors:  M A Colgin; R L Smith; C L Wilcox
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Effect of different whole body hyperthermic sessions on the heat shock response in mice liver and brain.

Authors:  S Leoni; D Brambilla; G Risuleo; G de Feo; G Scarsella
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

6.  The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice.

Authors:  K Wang; L Pesnicak; E Guancial; P R Krause; S E Straus
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant.

Authors:  D J Goldstein; S K Weller
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

8.  The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.

Authors:  C M Loiacono; N S Taus; W J Mitchell
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

9.  Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.

Authors:  Niveen M Mulholland; Edlyn Soeth; Catharine L Smith
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

10.  The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells.

Authors:  K Okazaki; N Sagata
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more
  10 in total

1.  The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.

Authors:  Michael D Gober; Jennifer M Laing; Scott M Thompson; Laure Aurelian
Journal:  Brain Res       Date:  2006-10-03       Impact factor: 3.252

Review 2.  The oncolytic virus ΔPK has multimodal anti-tumor activity.

Authors:  Laure Aurelian; Dominique Bollino; Aric Colunga
Journal:  Pathog Dis       Date:  2016-05-29       Impact factor: 3.166

3.  The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.

Authors:  Erin K Golembewski; Samantha Q Wales; Laure Aurelian; Paul J Yarowsky
Journal:  Exp Neurol       Date:  2006-10-16       Impact factor: 5.330

4.  Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice.

Authors:  Jennifer M Laing; Michael D Gober; Erin K Golembewski; Scott M Thompson; Kymberly A Gyure; Paul J Yarowsky; Laure Aurelian
Journal:  Mol Ther       Date:  2006-02-24       Impact factor: 11.454

5.  The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation.

Authors:  Samantha Q Wales; Baiquan Li; Jennifer M Laing; Laure Aurelian
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

6.  Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.

Authors:  Jennifer M Laing; Cynthia C Smith; Laure Aurelian
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

7.  The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.

Authors:  A G Colunga; J M Laing; L Aurelian
Journal:  Gene Ther       Date:  2009-10-01       Impact factor: 5.250

8.  H11/HspB8 and Its Herpes Simplex Virus Type 2 Homologue ICP10PK Share Functions That Regulate Cell Life/Death Decisions and Human Disease.

Authors:  Laure Aurelian; Jennifer M Laing; Ki Seok Lee
Journal:  Autoimmune Dis       Date:  2012-09-27

9.  Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors.

Authors:  Misaki Wayengera
Journal:  Theor Biol Med Model       Date:  2011-06-24       Impact factor: 2.432

10.  DeltaRR vaccination protects from KA-induced seizures and neuronal loss through ICP10PK-mediated modulation of the neuronal-microglial axis.

Authors:  Jennifer M Laing; Laure Aurelian
Journal:  Genet Vaccines Ther       Date:  2008-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.